Medical Oncologist
Clinical Director, Early Drug Development Service
Conditions Treated:
About Me
I am a medical oncologist who specializes in the treatment of lung cancer. I work with a team of experts including surgeons, radiation oncologists, pathologists, and nurses. Our goal is to provide the best possible care and support for patients and their families.
As a member of the Thoracic Oncology Service, my research is focused on developing new treatments for lung cancer. I have a particular interest in studying ways to target molecular changes in patients’ tumors with new medicines. I also specialize in early-phase clinical trials and am a member of our Developmental Therapeutics group. Our aim is to bring new drugs to patients with all types of cancer, particularly those for whom standard treatments have been exhausted. I speak English, Spanish, and Filipino.
See My Colleagues
Publications
Visit PubMed for a full listing of Alexander Drilon’s journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.Clinical Trials
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Alexander Drilon
Clinical Trials Co-Investigated by Alexander Drilon
Insurance
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.
Learn more
